Literature DB >> 33630123

[Esophagotracheal and esophagobronchial fistulas].

S Brunner1, C J Bruns1, W Schröder2,3.   

Abstract

Esophagobronchial and esophagotracheal fistulas are rare but complex diseases with a heterogeneous spectrum of underlying etiologies. Common causes are locally advanced tumors of the esophagus and larynx, traumatic perforation from the esophageal or tracheal side as well as postoperative fistulas. The management of esophagotracheal and esophagobronchial fistulas always involves different health care providers and in most cases patients require a multidisciplinary treatment on the intensive care unit. The therapeutic concept primarily depends on the underlying cause, localization and size of the fistula but decision making is also influenced by the severity of the course of sepsis and the extent of the respiratory dysfunction. Endoscopic management with esophageal and/or tracheobronchial stenting is the most common treatment. Surgical reconstructive procedures are predominantly reserved for patients with a treatment refractory fistula or a septic multiple organ failure. The prognosis is particularly influenced by the underlying disease.

Entities:  

Keywords:  Esophageal cancer; Esophageal stent; Esophagectomy; Plastic reconstructive surgery; Tracheal stent

Mesh:

Year:  2021        PMID: 33630123     DOI: 10.1007/s00104-021-01370-4

Source DB:  PubMed          Journal:  Chirurg        ISSN: 0009-4722            Impact factor:   0.955


  7 in total

1.  Utility of removable esophageal covered self-expanding metal stents for leak and fistula management.

Authors:  Shanda H Blackmon; Rachel Santora; Peter Schwarz; Alberto Barroso; Brian J Dunkin
Journal:  Ann Thorac Surg       Date:  2010-03       Impact factor: 4.330

2.  Palliation of Concomitant Tracheobronchial and Esophageal Disease Using a Combined Airway and Esophageal Approach.

Authors:  Basil S Nasir; Mehdi Tahiri; Jordan Kazakov; Vicky Thiffault; Pasquale Ferraro; Moishe Liberman
Journal:  Ann Thorac Surg       Date:  2016-05-05       Impact factor: 4.330

3.  Surgical management of acquired nonmalignant tracheoesophageal and bronchoesophageal fistulae.

Authors:  K Robert Shen; Mark S Allen; Stephen D Cassivi; Francis C Nichols; Dennis A Wigle; W Scott Harmsen; Claude Deschamps
Journal:  Ann Thorac Surg       Date:  2010-09       Impact factor: 4.330

4.  Long-Term Outcome of Definitive Chemoradiotherapy and Induction Chemoradiotherapy Followed by Surgery for T4 Esophageal Cancer with Tracheobronchial Invasion.

Authors:  Shohei Yamaguchi; Masaru Morita; Manabu Yamamoto; Akinori Egashira; Hiroyuki Kawano; Nao Kinjo; Eiji Tsujita; Kazuhito Minami; Masahiko Ikebe; Yasuharu Ikeda; Naonobu Kunitake; Yasushi Toh
Journal:  Ann Surg Oncol       Date:  2018-07-26       Impact factor: 5.344

5.  Surgical treatment of nonmalignant tracheoesophageal fistula: a thirty-five year experience.

Authors:  Ashok Muniappan; John C Wain; Cameron D Wright; Dean M Donahue; Henning Gaissert; Michael Lanuti; Douglas J Mathisen
Journal:  Ann Thorac Surg       Date:  2012-09-20       Impact factor: 4.330

6.  Endoscopic treatment of nonmalignant tracheoesophageal and bronchoesophageal fistula: results and prognostic factors for its success.

Authors:  Antoine Debourdeau; Jean-Michel Gonzalez; Hervé Dutau; Alban Benezech; Marc Barthet
Journal:  Surg Endosc       Date:  2018-07-16       Impact factor: 4.584

Review 7.  Endoscopic management of tracheoesophageal fistulas.

Authors:  Daryl Ramai; Alexis Bivona; William Latson; Andrew Ofosu; Emmanuel Ofori; Madhavi Reddy; Douglas G Adler
Journal:  Ann Gastroenterol       Date:  2018-10-29
  7 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.